Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning

Metformin is a first-line drug used for the treatment of type 2 diabetes. Recently, metformin has been reported to reduce the carcinogenic risk and inhibit tumor cell growth in glioma and breast cancer. The anticancer action of metformin involves the enhancement of phosphorylation of liver kinase B1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: IRIE, HARUKO, BANNO, KOUJI, YANOKURA, MEGUMI, IIDA, MIHO, ADACHI, MASATAKA, NAKAMURA, KANAKO, UMENE, KIYOKO, NOGAMI, YUYA, MASUDA, KENTA, KOBAYASHI, YUSUKE, TOMINAGA, EIICHIRO, AOKI, DAISUKE
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2016
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734273/
https://ncbi.nlm.nih.gov/pubmed/26893732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4075
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars